4/12
10:12 am
sln
Silence Therapeutics (SLN) Surges 5.7%: Is This an Indication of Further Gains? [Yahoo! Finance]
Low
Report
Silence Therapeutics (SLN) Surges 5.7%: Is This an Indication of Further Gains? [Yahoo! Finance]
4/8
11:58 am
sln
Silence Therapeutics Announces JAMA Publication of Additional Phase 1 Data for Zerlasiran in Subjects with Elevated Lipoprotein(a) [Yahoo! Finance]
Low
Report
Silence Therapeutics Announces JAMA Publication of Additional Phase 1 Data for Zerlasiran in Subjects with Elevated Lipoprotein(a) [Yahoo! Finance]
4/8
11:48 am
sln
Silence Therapeutics Announces JAMA Publication of Additional Phase 1 Data for Zerlasiran in Subjects with Elevated Lipoprotein(a)
Neutral
Report
Silence Therapeutics Announces JAMA Publication of Additional Phase 1 Data for Zerlasiran in Subjects with Elevated Lipoprotein(a)
3/18
03:09 pm
sln
Silence Therapeutics plc (NASDAQ: SLN) had its price target raised by analysts at Chardan Capital from $26.00 to $42.00. They now have a "buy" rating on the stock.
Low
Report
Silence Therapeutics plc (NASDAQ: SLN) had its price target raised by analysts at Chardan Capital from $26.00 to $42.00. They now have a "buy" rating on the stock.
3/18
03:05 pm
sln
Silence Therapeutics plc (NASDAQ: SLN) had its price target raised by analysts at Morgan Stanley from $29.00 to $45.00. They now have an "overweight" rating on the stock.
Low
Report
Silence Therapeutics plc (NASDAQ: SLN) had its price target raised by analysts at Morgan Stanley from $29.00 to $45.00. They now have an "overweight" rating on the stock.
3/18
02:56 pm
sln
Silence Therapeutics plc (NASDAQ: SLN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $75.00 price target on the stock.
Low
Report
Silence Therapeutics plc (NASDAQ: SLN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $75.00 price target on the stock.
3/16
08:57 am
sln
Analysts Are Upgrading Silence Therapeutics plc (NASDAQ:SLN) After Its Latest Results [Yahoo! Finance]
Medium
Report
Analysts Are Upgrading Silence Therapeutics plc (NASDAQ:SLN) After Its Latest Results [Yahoo! Finance]
3/15
12:07 pm
sln
Silence Therapeutics plc (NASDAQ:SLN) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Silence Therapeutics plc (NASDAQ:SLN) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
3/13
07:05 am
sln
Silence Therapeutics Reports Full Year 2023 Financial Results and Recent Business Highlights
High
Report
Silence Therapeutics Reports Full Year 2023 Financial Results and Recent Business Highlights
3/13
07:00 am
sln
Silence Therapeutics Announces Positive Topline 36-Week Data from Ongoing Phase 2 Study of Zerlasiran in Patients with High Lipoprotein(a)
Medium
Report
Silence Therapeutics Announces Positive Topline 36-Week Data from Ongoing Phase 2 Study of Zerlasiran in Patients with High Lipoprotein(a)
2/28
08:00 am
sln
Silence Therapeutics to Report Fourth Quarter and Full Year 2023 Results on March 13, 2024
Low
Report
Silence Therapeutics to Report Fourth Quarter and Full Year 2023 Results on March 13, 2024
2/24
09:00 pm
sln
Silence Therapeutics: Multiple 2024 Catalysts Make This mRNA Biotech Worth A Look [Seeking Alpha]
Low
Report
Silence Therapeutics: Multiple 2024 Catalysts Make This mRNA Biotech Worth A Look [Seeking Alpha]
2/23
08:00 am
sln
Silence Therapeutics Achieves $10 Million Milestone Payment from AstraZeneca Collaboration Following the Initiation of Phase 1 Trial
Low
Report
Silence Therapeutics Achieves $10 Million Milestone Payment from AstraZeneca Collaboration Following the Initiation of Phase 1 Trial
2/22
09:04 am
sln
Silence Therapeutics plc (NASDAQ: SLN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $75.00 price target on the stock.
Low
Report
Silence Therapeutics plc (NASDAQ: SLN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $75.00 price target on the stock.
2/7
08:17 am
sln
Broker Revenue Forecasts For Silence Therapeutics plc (NASDAQ:SLN) Are Surging Higher [Yahoo! Finance]
Low
Report
Broker Revenue Forecasts For Silence Therapeutics plc (NASDAQ:SLN) Are Surging Higher [Yahoo! Finance]
2/5
08:25 am
sln
Silence Therapeutics Announces Oversubscribed $120 Million Private Placement [Yahoo! Finance]
Medium
Report
Silence Therapeutics Announces Oversubscribed $120 Million Private Placement [Yahoo! Finance]
2/5
08:00 am
sln
Silence Therapeutics Announces Oversubscribed $120 Million Private Placement
Low
Report
Silence Therapeutics Announces Oversubscribed $120 Million Private Placement
1/31
08:07 am
sln
Silence Therapeutics plc (NASDAQ: SLN) is now covered by analysts at BMO Capital Markets. They set an "outperform" rating and a $67.00 price target on the stock.
High
Report
Silence Therapeutics plc (NASDAQ: SLN) is now covered by analysts at BMO Capital Markets. They set an "outperform" rating and a $67.00 price target on the stock.
1/31
07:00 am
sln
Silence Therapeutics to Participate in Fireside Chat at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
High
Report
Silence Therapeutics to Participate in Fireside Chat at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
1/25
05:31 pm
sln
Global mRNA-based Vaccines and Therapeutics Market is Projected to Grow Immensely During the Study Period (2019-2032) | DelveInsight
Low
Report
Global mRNA-based Vaccines and Therapeutics Market is Projected to Grow Immensely During the Study Period (2019-2032) | DelveInsight
1/25
05:31 pm
sln
Global mRNA-based Vaccines and Therapeutics Market is Projected to Grow Immensely During the Study Period (2019-2032) | DelveInsight
Low
Report
Global mRNA-based Vaccines and Therapeutics Market is Projected to Grow Immensely During the Study Period (2019-2032) | DelveInsight
1/20
08:57 am
sln
Insiders the biggest winners as Silence Therapeutics plc's (NASDAQ:SLN) market cap rises to US$736m [Yahoo! Finance]
Low
Report
Insiders the biggest winners as Silence Therapeutics plc's (NASDAQ:SLN) market cap rises to US$736m [Yahoo! Finance]